B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sulfisomidine

73 PubMed studies analyzed ยท Evidence Score: 41.2

Research Domains

Sulfisomidine has been studied across 11 research domains including ๐Ÿฆ  Gut & Microbiome, ๐Ÿซ˜ Kidney, ๐Ÿง  Focus & Attention, ๐Ÿ”ฅ Metabolic, ๐Ÿ”ฌ Oncology. The primary research focus is ๐Ÿฆ  Gut & Microbiome with 6% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sulfisomidine is generated deterministically from 73 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.